MedTrace Logo

International Lung Screen Trial (ILST)

NCT02871856 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2023-12-05

No results posted yet for this study

Summary

People who may be at increased risk of lung cancer due to age and smoking history will be invited to participate in this international study to determine the best way of using computed tomography (CT) of the chest to screen for early lung cancer. Overseas data show that CT screening (screening tests can find diseases early, when they're easier to treat) can reduce deaths from lung cancer and this study will help determine who is most likely benefit from screening.

Conditions

  • Non-small Cell Lung Cancer
  • Lung Neoplasms
  • Respiratory Tract Neoplasms
  • Thoracic Neoplasms
  • Neoplasms by Site
  • Neoplasms
  • Lung Diseases
  • Respiratory Tract Diseases
  • Smokers at Risk of Lung Cancer

Interventions

DIAGNOSTIC_TEST

Low dose CT

low-dose screening CT of chest for lung cancer detection

Sponsors & Collaborators

  • The University of Queensland

    lead OTHER

Principal Investigators

  • Kwun M Fong · UQTRC at TPCH

  • Steven Lam · British Columbia Cancer Agency

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-05
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Australia
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02871856 on ClinicalTrials.gov